BNR vs. RCAT, ZENV, DOMA, ARQQ, SKYX, ARRW, FAAS, ALLT, RR, and BGSF
Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Red Cat (RCAT), Zenvia (ZENV), Doma (DOMA), Arqit Quantum (ARQQ), SKYX Platforms (SKYX), Arrowroot Acquisition (ARRW), DigiAsia (FAAS), Allot Communications (ALLT), Richtech Robotics (RR), and BGSF (BGSF). These companies are all part of the "business services" sector.
Red Cat (NASDAQ:RCAT) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment, community ranking and analyst recommendations.
38.0% of Red Cat shares are held by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are held by institutional investors. 31.2% of Red Cat shares are held by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Red Cat had 4 more articles in the media than Burning Rock Biotech. MarketBeat recorded 4 mentions for Red Cat and 0 mentions for Burning Rock Biotech. Red Cat's average media sentiment score of 0.73 beat Burning Rock Biotech's score of 0.29 indicating that Burning Rock Biotech is being referred to more favorably in the news media.
Burning Rock Biotech has a net margin of -121.79% compared to Burning Rock Biotech's net margin of -206.42%. Burning Rock Biotech's return on equity of -52.40% beat Red Cat's return on equity.
Red Cat has higher earnings, but lower revenue than Burning Rock Biotech. Red Cat is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.
Burning Rock Biotech received 3 more outperform votes than Red Cat when rated by MarketBeat users. However, 100.00% of users gave Red Cat an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote.
Summary
Red Cat beats Burning Rock Biotech on 9 of the 14 factors compared between the two stocks.
Get Burning Rock Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Burning Rock Biotech Competitors List
Related Companies and Tools
